Calcineurin–Nuclear factor of activated T-cells docking interface (Cn–NFAT interface)

Calcineurin–Nuclear factor of activated T-cells docking interface Overview

The Calcineurin–NFAT docking interface is a specialized protein-protein interaction site essential for the calcium-dependent signaling pathway that governs T-cell activation. Calcineurin, a serine/threonine phosphatase, recognizes and binds to the Nuclear Factor of Activated T-cells (NFAT) through two distinct conserved motifs: the high-affinity PxIxIT motif and the C-terminal LxVP motif (PubMed: 11430833, 17412991). Upon binding, calcineurin dephosphorylates multiple residues on NFAT, exposing its nuclear localization signal and allowing it to translocate into the nucleus to initiate the transcription of pro-inflammatory cytokines like IL-2 (UniProt: P17544). While classic inhibitors like Cyclosporine A and Tacrolimus effectively block this pathway by forming complexes that sterically hinder the active site, they often lead to off-target toxicity because they inhibit calcineurin's phosphatase activity toward all substrates (PubMed: 19144315). Modern therapeutic strategies focus on small molecules or peptides, such as the VIVIT peptide, that specifically compete for the docking interface to selectively inhibit NFAT activation without disrupting other vital calcineurin-mediated processes (PubMed: 11430833). This interface represents a high-value target for developing more precise immunosuppressive and anti-inflammatory agents with reduced side-effect profiles.

Mechanism of Action

Inhibition of protein-protein interaction between calcineurin and NFAT, preventing NFAT dephosphorylation and subsequent nuclear translocation.

Biological Functions

Safety Considerations

Interacting Drugs

Associated Biomarkers